Skip to main content

Table 3 Mean total scores for pre-rotation and post-rotation tests (scores are expressed as a total score out of 100)

From: A web-based simulation of a longitudinal clinic used in a 4-week ambulatory rotation: a cohort study

 

Control group

Intervention group

 

Pre-rotation

Post-rotation

P-value

Pre-rotation

Post-rotation

P-value

Total score

62.2

68.2

.023 *

60.9

82.6

< .001*

By type of patient encounter:

      

Initial consultation

59.8

70.1

.023*

58.6

81.6

< .001*

Follow-up care

65.2

66.3

.717

63.6

83.6

< .001*

Diagnosis

53.2

67.1

.015*

50.7

83.6

< .001*

Initiating therapy

64.9

72.5

.072

64.4

80.1

.001*

Natural history

52.2

71.2

.094

49.6

87.0

< .001*

Managing treatment

60.4

52.3

.116

54.9

74.9

.003*

Pregnancy

63.4

63.8

.944

63.5

85.5

.001*

Practice management

73.6

82.8

.072

71.2

80.4

.039*

All COCOS cases†:

66.5

70.4

.152

61.5

80.1

< .001*

Type 1 diabetes

70.7

79.5

.041*

68.2

85.1

< .001*

Graves disease

68.8

65.3

.537

59.6

76.6

.018*

Hyperprolactinemia

54.7

59.3

.554

50.6

77.2

.001*

All non-COCOS cases††

60.3

65.1

.285

60.3

84.9

<.001*

Type 2 diabetes

58.0

76.3

.019*

61.9

90.5

<.001*

Thyroid nodules

68.2

56.4

.008*

68.6

78.3

.060

Polycystic ovarian syndrome

48.8

56.1

.434

52.4

81.7

<.001*

  1. * Significant p-value (< 0.05), paired t-test
  2. † : cumulative score for questions pertaining to topics for which COCOS cases were written (type 1 Diabetes, Graves disease and Hyperprolactinemia)
  3. ††: cumulative score for questions pertaining to topics for which COCOS cases were not written (type 2 Diabetes, thyroid nodules, polycystic ovarian syndrome)